Allovir Inc
For the period ended Dec 31, 2024. Filed Mar 7, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 7, 2025
KLRS$2.30-5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
| Common Stock · AdditionalPaid-In · AccumulatedOtherComprehensive · Accumulated · TotalStockholders’ | ||||||
|---|---|---|---|---|---|---|
| (in thousands, except share amounts) | Shares | Amount | Capital | (Loss) Income | Deficit | Equity |
| Balance at December 31, 2022 | 4,047,531 | $— | $690,762 | $(468) | $(465,775) | $224,519 |
| Stock-based compensation | — | — | 40,779 | — | — | 40,779 |
| Issuance of common stock, upon vesting of restricted stock | 40,065 | — | — | — | — | — |
| Purchase of common stock under the 2020 Employee Stock Purchase Plan | 5,836 | — | 326 | — | — | 326 |
| Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs | 869,565 | — | 70,169 | — | — | 70,169 |
| Unrealized gain on available-for-sale securities | — | — | — | 406 | — | 406 |
| Net loss | — | — | — | — | (190,418) | (190,418) |
| Balance at December 31, 2023 | 4,962,997 | $— | $802,036 | $(62) | $(656,193) | $145,781 |
| Stock-based compensation | — | — | 26,347 | — | — | 26,347 |
| Issuance of common stock, upon vesting of restricted stock | 76,061 | — | — | — | — | — |
| Purchase of common stock under the 2020 Employee Stock Purchase Plan | 1,582 | — | 21 | — | — | 21 |
| Unrealized loss on available-for-sale securities | — | — | — | (73) | — | (73) |
| Net loss | — | — | — | — | (58,769) | (58,769) |
| Balance at December 31, 2024 | 5,040,640 | $— | $828,404 | $(135) | $(714,962) | $113,307 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.